MedXCell SA selected to participate in the sixth edition of the pre-IPO program TechShare organized by Euronext
Montreux, Switzerland | January 21, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and